A physiologist's view of the N‐methyl‐D‐Aspartate receptor: An allosteric ion channel with multiple regulatory sites

A physiologist's view of the N‐methyl‐D‐Aspartate receptor: An allosteric ion channel with... Whole‐cell and single‐channel recording techniques have provided a great deal of information about the nature of the N‐methyl‐D‐aspartate (NMDA) receptor channel complex and are beginning to lead to quasimolecular models of drug action. Currently five ligand‐binding domains are known to exist on the NMDA receptor channel complex: 1) an agonist‐binding site for which structural analogues of L‐glutamate have been developed as competitive antagonists; 2) a divalent cation‐binding site within the ion channel pore, at which Mg binds to produce voltage‐dependent channel block; 3) a divalent cation‐binding site near the extracellular face of the membrane, at which Zn and Cd but not Mg bind to produce a voltage‐independent block; 4) an anaesthetic binding site within the pore, at which ketamine, phencyclidine, MK‐801, and desipramine bind with high affinity to produce voltage‐dependent ion channel block of long duration; and 5) a regulatory site on the extracellular face of the membrane at which glycine binds to promote NMDA receptor channel activity. This potentiating action of glycine, to a large extent, reflects a block of fast desensitization, via an increase in the rate constant for return of desensitized NMDA receptors to their resting state. Drugs that competitively displace glycine from its binding site, but that are without glycine‐like activity, act as noncompetitive NMDA receptor antagonists. The combination of these unusual physiological and pharmacological properties seems to have been exploited in the brain to allow the NMDA receptor to gate a variety of complex behaviours, including memory formation, neuronal cell death in stroke and ischemia, and electrical excitability in epilepsy. The existence of multiple ligand‐binding sites on the NMDA receptor complex provides many potential avenues for the development of new classes of centrally active drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Development Research Wiley

A physiologist's view of the N‐methyl‐D‐Aspartate receptor: An allosteric ion channel with multiple regulatory sites

Loading next page...
 
/lp/wiley/a-physiologist-s-view-of-the-n-methyl-d-aspartate-receptor-an-DCG5t59g8t
Publisher
Wiley
Copyright
Copyright © 1989 Wiley‐Liss, Inc., A Wiley Company
ISSN
0272-4391
eISSN
1098-2299
D.O.I.
10.1002/ddr.430170404
Publisher site
See Article on Publisher Site

Abstract

Whole‐cell and single‐channel recording techniques have provided a great deal of information about the nature of the N‐methyl‐D‐aspartate (NMDA) receptor channel complex and are beginning to lead to quasimolecular models of drug action. Currently five ligand‐binding domains are known to exist on the NMDA receptor channel complex: 1) an agonist‐binding site for which structural analogues of L‐glutamate have been developed as competitive antagonists; 2) a divalent cation‐binding site within the ion channel pore, at which Mg binds to produce voltage‐dependent channel block; 3) a divalent cation‐binding site near the extracellular face of the membrane, at which Zn and Cd but not Mg bind to produce a voltage‐independent block; 4) an anaesthetic binding site within the pore, at which ketamine, phencyclidine, MK‐801, and desipramine bind with high affinity to produce voltage‐dependent ion channel block of long duration; and 5) a regulatory site on the extracellular face of the membrane at which glycine binds to promote NMDA receptor channel activity. This potentiating action of glycine, to a large extent, reflects a block of fast desensitization, via an increase in the rate constant for return of desensitized NMDA receptors to their resting state. Drugs that competitively displace glycine from its binding site, but that are without glycine‐like activity, act as noncompetitive NMDA receptor antagonists. The combination of these unusual physiological and pharmacological properties seems to have been exploited in the brain to allow the NMDA receptor to gate a variety of complex behaviours, including memory formation, neuronal cell death in stroke and ischemia, and electrical excitability in epilepsy. The existence of multiple ligand‐binding sites on the NMDA receptor complex provides many potential avenues for the development of new classes of centrally active drugs.

Journal

Drug Development ResearchWiley

Published: Jan 1, 1989

Keywords: patch clamp; ion channel block; desensitization; allosteric regulation

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off